Green Valley Obtains IND Approval from U.S. FDA for Sodium Oli...
SHANGHAI, April 27, 2020 /PRNewswire-AsiaNet/ -- On April 8, 2020, Shanghai Green Valley Pharmaceuticals, China received the formal decision letter from the US Food and Drug Administration (FDA) on the Investigational New Drug (IND) application for the GV-971 international multi-center Phase III...
Authors: LATEST ASIANET NEWS RELEASES